Receptor-effector coupling dysfunctions in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 786, Issue , 1996, Pages 294-304

  Fowler, Christopher J ^a   Garlind, Anita ^b   O'Neill, Cora ^c   Cowburn, Richard F ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; PROTEIN KINASE C;

ALZHEIMER DISEASE; BRAIN CORTEX; CEREBELLUM; CONFERENCE PAPER; DISEASE COURSE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; NEUROPATHOLOGY; POSTSYNAPTIC POTENTIAL; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR EFFECTOR COUPLING; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0029778243     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb39072.x     Document Type: Conference Paper

References (72)

1. TOMLINSON, B. E. & J. A. N. CORSELLIS. 1984. Ageing and the dementias. In Greenfield's Neuropathology. 4th edit. J. H. Adams, J. A. N. Corsellis & L. W. Duchen, Eds. 951-1025. John Wiley & Sons Inc. New York.
2. TERRY, R. D., E. MASLIAH & L. A. HANSEN. 1994. Structural basis of the cognitive alterations in Alzheimer's disease. In Alzheimer's Disease. R. D. Terry, R. Katzman & K. L. Bick, Eds. 179-196. Raven Press. New York.
3. PALMER, A. M. & D. M. BOWEN. 1990. Neurochemical basis of dementia of the Alzheimer type: contribution of postmortem and antemortem studies. In Biological Markers in Dementia of Alzheimer Type. C. J. Fowler, L. A. Carlson, C. G. Gottfries & B. Winblad, Eds. 89-105. Smith-Gordon & Co Ltd. London.
4. FOWLER, C. J., C. O'NEILL, A. GARLIND & R. F. COWBURN. 1990. Alzheimer's disease: is there a problem beyond recognition? Trends Pharmacol. Sci. 11: 183-184.
5. FOWLER, C. J., C. O'NEILL, B. WINBLAD & R. F. COWBURN. 1992. Neurotransmitter, receptor, and signal transduction disturbances in Alzheimer's disease. Acta Neurol. Scand. 139(Suppl.): 59-62.
6. GREENAMYRE, J. T. & W. F. MARAGOS. 1993. Neurotransmitter receptors in Alzheimer's disease. Cerebrovasc. Brain Metab. Revs. 5: 61-94.
7. WHITEHOUSE, P. J., A. M. MARTINO, P. G. ANTUONO, P. R. LOWENSTEIN, J. T. COYLE, D. L. PRICE & K. L. KELLAR. 1986. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371: 146-151.
8. GREENAMYRE, T. J., J. B. PENNEY, A. B. YOUNG, C. J. D'AMATO, S. P. HICKS & I. SHOULSON. 1985. Alterations in L-glutamate binding in Alzheimer's and Huntington's disease. Science 227: 1496-1499.
9. GEDDES, J. W., H. CHANG-CHUI, S. M. COOPER, I. T. LOTT & C. W. COTMAN. 1986. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res. 399: 156-161.
10. PALMER, A. M. & M. A. BURNS. 1994. Preservation of redox, polyamine and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease. J. Neurochem. 62: 187-196.
11. CHALMERS, D. T., D. DEWAR, D. I. GRAHAM, D. N. BROOKS & J. MCCULLOCH. 1990. Differential alterations of cortical glutaminergic binding sites in senile dementia of the Alzheimer type. Proc. Natl. Acad. Sci. USA 87: 1352-1356.
12. COWBURN, R. F., J. A. HARDY, R. BRIGGS & P. J. ROBERTS. 1989. Characterization, density and distribution of kainate receptors in normal and Alzheimer's diseased brain. J. Neurochem. 52: 140-147.
13. A receptor changes in Alzheimer's disease. Neurosci. Lett 82: 246-252.
14. MASH, D. C., D. D. FLYNN & L. T. PORTER. 1985. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 228: 1115-1117.
15. SHIMOHAMA, S., T. TANIGUCHI, M. FUJIWARA & M. KAMEYAMA. 1986. Biochemical characterization of α-adrenergic receptors in human brain and changes in Alzheimer-type dementia. J. Neurochem. 47: 1294-1301.
16. 3H]p-aminoclonidine binding in prefrontal cortex. Neurobiol. Aging 12: 131-136.
17. SHIMOHAMA, S., T. TANIGUCHI, M. FUJIWARA & M. KAMEYAMA. 1987. Changes in β-adrenergic receptor subtypes in Alzheimer-type dementia. J. Neurochem. 48: 1215-1221.
18. MIDDLEMISS, D. N., A. M. PALMER, N. EDEL & D. M. BOWEN. 1986. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin in normal and Alzheimer brain. J. Neurochem. 46: 993-996.
19. CROSS, A. J., T. J. CROW, J. A. JOHNSON, E. K. PERRY, R. H. PERRY, G. BLESSED & B. E. TOMLINSON. 1984. Studies on neurotransmitter receptor systems in the neocortex and hippocampus in senile dementia of the Alzheimer type. J. Neural. Sci. 64: 109-117.
20. A receptors in Alzheimer's disease: a quantitative autoradiographic study. Neurology 37: 1454-1459.
21. 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's disease. Neurosci. Lett. 185: 131-134.
22. WATSON, S. & D. GIRDLESTONE. 1995. Trends Pharamcol. Sci. 1995 Receptor Nomenclature Supplement.
23. RANG, H. P., M. M. DALE & J. M. RITTER. 1995. In Pharmacology. 3rd Edit. 26-43. Churchill Livingstone. Edinburgh.
24. STOKES, C. E. & J. N. HAWTHORNE. 1987. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J. Neurochem. 48: 1018-1021.
25. COWBURN, R. F., C. O'NEILL, R. RAVID, I. ALAFUZOFF, B. WINBLAD C. J. FOWLER. 1992. Adenylyl cyclase activity in post-mortem human brain: evidence of altered G protein mediation in Alzheimer's disease. J. Neurochem. 58: 1409-1419.
26. 3H]forskolin binding sites in Alzheimer's disease: a quantative autoradiographic study. Brain Res. 511: 241-248.
27. WANG, H-Y. & E. FRIEDMAN. 1994. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. Neurosci. Lett. 173: 37-39.
28. 1-adrenoceptor-G protein coupling in the temporal cortex of patients with Alzheimer's disease. Neurosci. Lett. 155: 163-166.
29. sα) mRNA in hippocampal and cortical neurons. Mol. Brain Res. 10: 71-81.
30. ROSS, B. M., M. MCLAUGHLIN, M. ROBERTS, G. MILLIGAN, J. MCCULLOCH & J. T. KNOWLER. 1993. Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Res. 622: 35-42.
31. O'NEILL, C., B. WIEHAGER, C. J. FOWLER, R. RAVID, B. WINBLAD & R. F. COWBURN. 1994. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain. Brain Res. 636: 193-201.
32. i-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease. Neurosci. Lett. 141: 16-20.
33. 1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease. Neurosci. Lett. 133: 15-19.
34. 2-adrenoceptors to GTP-binding proteins in Alzheimer's disease. Brain Res. 563: 39-43.
35. BERGSTRÖM, L., A. GARLIND, L. NILSSON, I. ALAFUZOFF, C. J. FOWLER, B. WINBLAD & R. F. COWBURN. 1991. Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain. J. Neurol. Sci. 105: 225-233.
36. ULAS, J., L. C. BRUNNER, L. NGUYEN & C. W. COTMAN. 1993. Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study. Neuroscience 52: 843-854.
37. HERNANDÉZ-HERNANDÉZ, A., A. ADEM, R. RAVID & R. F. COWBURN. 1995. Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease. Neurosci. Lett. 186: 57-60.
38. 3H]oxotremorine-M binding in normal and Alzheimer's disease parietal cortex: an index of muscarinic receptor-G protein coupling. Biochem. Soc. Trans. 17: 202-203.
39. OHM, T. G., J. BOHL & B. LEMMER. 1991. Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes. Brain Res. 540: 229-236.
40. SHIMOHAMA, S., S. FUJIMOTO, H. MATSUSHIMA, T. TAKENAWA, T. TANIGUCHI, G. PERRY, P. J. WHITEHOUSE & J. KIMURA. 1995. Alteration of phospholipase C-δ protein level and specific activity in Alzheimer's disease. J. Neurochem. 64: 2629-2634.
41. DANIELSSON, E., S-Å. ECKERNÄS, A. WESTLIND-DANIELSSON, Ö. NORDSTRÖM, T. BARTFAI, C-G. GOTTFRIES & A. WALLIN. 1988. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type. Neurobiol. Aging 9: 153-162.
42. SCHNECKO, A., K. WITTE, J. BOHL, T. OHM & B. LEMMER. 1994. Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected. Brain Res. 644: 291-296.
43. COWBURN, R. F., C. J. FOWLER, A. GARLIND, I. ALAFUZOFF, L. NILSSON, B. WINBLAD & L. BERGSTRÖM. 1991. Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 54: 748-749.
44. 2 hydrolysis in Alzheimer's disease. Life Sci. 53: 439-444.
45. PARKS, K. M., J. E. SUGAR, V. HAROUTUNIAN, L. BIERER, D. PERL & W. C. WALLACE. 1991. Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem samples. Mol. Brain Res. 9: 125-134.
46. COLE, G., K. R. DOBKINS, L. A. HANSEN, R. D. TERRY & T. SAITOH. 1988. Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 452: 165-174.
47. MASLIAH, E., G. M. COLE, S. SHIMOHAMA, L. A. HANSEN, R. DETERESA, R. D. TERRY & T. SAITOH. 1990. Differential involvement of protein kinase C isoenzymes in Alzheimer's disease. J. Neurosci. 10: 2113-2124.
48. 3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease. Neurosci. Lett. 94: 198-202.
49. 4 binding in Alzheimer's disease brain. Brain Res. 681: 160-166.
50. HARIK, S. I., M. J. MITCHELL & R. N. KALARIA. 1989. Ouabain binding in the human brain. Effects of Alzheimer's disease and aging. Arch. Neurol. 46: 951-954.
51. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15: 259-264.
52. HUANG, H-M. & G. E. GIBSON. 1993. Altered β-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J. Biol. Chem. 268: 14616-14621.
53. BLASS, J. P., G. E. GIBSON, R. S. BLACK, L-W. KO & K.-F. R. SHEU. 1990. Cultured skin fibroblasts, "Alzheimer antigens," and cellular calcium homeostasis in Alzheimer's disease. In Biological Markers in Dementia of Alzheimer Type. C. J. Fowler, L. A. Carlson, C. G. Gottfries & B. Winblad, Eds. 203-214. Smith-Gordon & Co, Ltd. London.
54. BRUEL, A., G. CHERQUI, S. COLUMELLI, D. MARGELIN, M. ROUDIER, P-M. SINET, M. PRIEUR, J-L. PÉRIGNON & J. DELABAR. 1991. Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts. Neurosci. Lett. 133: 89-92.
55. WARPMAN, U., I. ALAFUZOFF & A. NORDBERG. 1993. Coupling of muscarinic receptors to GTP proteins in postmortem human brain-alterations in Alzheimer's disease. Neurosci. Lett. 150: 39-43.
56. MATTSON, M. P., B. CHENG, D. DAVIS, K. BRYANT, I. LIEBERBURG & R. E. RYDEL. 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
57. HARDY, J. A. & G. A. HIGGINS. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
58. 2+ influx in PC12h cells in culture. Neurosci. Lett 173: 147-150.
59. CHAUHAN, A., V. P. S. CHAUHAN, H. BROCKERHOFF & H. M. WISNIEWSKI. 1991. Action of amyloid beta-protein on protein kinase C activity. Life Sci. 49: 1555-1562.
60. WALLACE, M. A. 1994. Effects of Alzheimer's disease-related β amyloid protein fragments on enzymes metabolizing phosphoinositides in brain. Biochim. Biophys. Acta 1227: 183-187.
61. COWBURN, R. F., B. WIEHAGER & E. SUNDSTRÖM. 1995. β-Amyloid peptides enhance binding of the calcium mobilizing second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes. Neurosci. Lett. 191: 31-34.
62. SAITO, K-I., J. S. ELCE, J. E. HAMOS & R. A. NIXON. 1993. Widespread activation of calcium-activated neutral protease (calpain) in the brain in Alzheimer disease: a potential molecular basis of neuronal degeneration. Proc. Natl. Acad. Sci. USA 90: 2628-2632.
63. 2+ channel. FEBS Lett. 323: 229-232.
64. GILLESPIE, S. L., T. E. GOLDE & S. G. YOUNKIN. 1992. Secretory processing of the Alzheimer amyloid β/A4 protein precursor is increased by protein phosphorylation. Biochem. Biophys. Res. Commun. 187: 1285-1290.
65. HUNG, A. Y., C. HAASS, R. M. NITSCH, W. Q. QIU, M. CITRON, R. J. WURTMAN, J. H. GROWDON & D. J. SELKOE. 1993. Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268: 22959-22962.
66. BUXBAUM, J. D., E. H. KOO & P. GREENGARD. 1993. Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide. Proc. Natl. Acad. Sci. USA 90: 9195-9198.
67. NITSCH, R. M., B. E. SLACK, R. J. WURTMAN & J. H. GROWDON. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 255: 304-307.
68. BUXBAUM, J. D., M. OISHI, H. I. CHEN, R. PINKAS-KRAMARSKI, E. A. JAFFE, S. E. GANDY & P. GREENGARD. 1992. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89: 10075-10078.
69. NITSCH, R. M., S. A. FARBER, J. H. GROWDON & R. J. WURTMAN. 1993. Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90: 5191-5193.
70. NITSCH, R. M. & J. H. GROWDON. 1994. Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47: 1275-1284.
71. STRITTMATTER, W. J., A. M. SAUNDERS, D. SCHMECKEL, M. PERICAK-VANCE, I. ENGHILD, G. S. SALVESEN & A. D. ROSES. 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type-4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
72. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.